ÂÜÀòÂÒÂ×

Having initially joined LGC as a BU Director in 2011, Mark Dearden went on to serve as Vice President of Strategy and Marketing for the Genomics Division. In this role, Mark was responsible for the Division’s M&A activities, partnering, organic product development and marketing communications activities. Mark was appointed as Managing Director of the Genomics Division in July 2020.

Prior to LGC, Mark has held diverse International leadership positions in General Management, Marketing, Product Management and Sales with leading life sciences companies such as GE Healthcare and Thermo Scientific. Mark has a BSc (honours) from University of Sydney and an MBA from Warwick Business School.